Peptides May Soon Be Legal: Companies Prepare for Market Bonanza
An FDA advisory panel is expected to recommend legal production of up to seven peptides, including popular injectables like BPC-157 and TB-500, currently sold in a gray market worth an estimated $3 billion. Compounding pharmacies such as Empower Pharmacy and Strive Pharmacy, along with telehealth companies like Hims & Hers and Wheel, are preparing for a potential multi-billion-dollar market. The panel's recommendation, anticipated by online commentators as 'Peptide Liberation Day,' will go to the FDA for final approval, which could take months to over a year. Supporters, including HHS Secretary Robert F. Kennedy Jr., argue legalization will improve safety, while critics warn of unproven efficacy and potential for 'snake oil' products. The FDA's own technical staff has recommended against expanded access.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection